Ara
Toplam kayıt 6, listelenen: 1-6
Atypical fibroxanthoma arising on chronic burn scar: A rare case report and the review of the literature
(Springer, 2018)
Atypical Fibroxanthoma (AFX) is a rare cutaneous mesenchymal neoplasm, predominantly found on sundamaged skin of the head and neck in elderly patients. But uncommonly it can develop on a burn scar with or without actinic ...
Rahim ağzı (serviks) kanserinde öncü lezyonların evrişimsel sinir aglarıyla bölütlenmesi
(IEEE, 2017)
Ülkemizde ve dünyada en sık görülen kanser tiplerinden olan rahim ağzı (serviks) kanseri, kanser öncüsü lezyonlarından gelişmektedir. Kanser öncüsü bu lezyonların saptanması, hastanın kanser olmadan tedavi olmasına olanak ...
Prognostic significance of positive lymph node ratio in patients with pN3 gastric cancer who underwent curative gastrectomy
(Oxford University Press, 2017)
Introduction: Lymph node metastasis is an important prognostic factor for patients with gastric cancer. The aim of this study was to determine the prognostic significance of metastatic lymph node ratio (MLNR) in pN3 gastric ...
Rituximab-vemurafenib combination for the treatment of relapsed/Refractory hairy cell leukemia
(CIG Media Group, 2020)
Objective: The management of R/R-HCL is not standardized yet. Patients with HCL universally harbor BRAF mutations, which makes BRAF inhibitors a potential treatment approach. The effi cacy and safety of the BRAF inhibitor ...
En bloc resection of bladder tumours: Histopathologic features of a prospective study
(Springer, 2021)
Background and Aims: The aim of the present study was to evaluate the characteristics of patients with acute liver failure (ALF) who underwent liver transplantation (LT) at 14 centers in Turkey and to determine factors ...
Adult case series of extramedullary relapsing acute myeloid leukemia (AML) after allogeneic stem cell transplantation in whom a rapid response and a reasonably long remission could be achieved with gemtuzumab ozogamycin (GO)
(The American Society of Hematology, 2019)
Gemtuzumab Ozogamycin (GO) is a drug conjugated monoclonal antibody which targets CD33 an antigen highly expressed on the surface of AML blasts. GO is approved for the treatment of both newly-diagnosed and relapsed AML. ...